MRNA CHMP opinion: Thursday, September 17, 2026
Variation type II · mRESVIA · Update of sections 4.2, 4.3 and 4.8 of the SmPC in order to add a new contraindication in children younger than 8 months of age because of an increased risk of RSV enhanced respiratory disease (ERD), following re-evaluation of the signal of RSV-ERD in children immunized
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.